D-Index & Metrics Best Publications

T. Kendall Harden

University of North Carolina at Chapel Hill
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Chemistry D-index 68 Citations 15,086 151 World Ranking 4049 National Ranking 1397

Biology and Biochemistry D-index 68 Citations 15,112 151 World Ranking 4984 National Ranking 2440

Research.com Recognitions

Awards & Achievements

2014 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study T. Kendall Harden is best known for:

Enzyme
Gene
G protein-coupled receptor

In the field of Endocrinology T. Kendall Harden connects related research areas like Cyclase, Catecholamine, Hormone and Stimulation. His Hormone study frequently draws parallels with other fields, such as Internal medicine. Internal medicine and Cyclase are commonly linked in his work. His research combines Endocrinology and Stimulation. Adrenergic and Agonist are fields of study that overlap with his Adrenergic receptor research. He connects Agonist with Adrenergic receptor in his study. Receptor connects with themes related to Inositol in his study. His work often combines Biochemistry and Biophysics studies. With his scientific publications, his incorporates both Enzyme and Receptor.

His most cited work include:

NOMENCLATURE AND CLASSIFICATION OF PURINOCEPTORS (482 citations)
P2-Purinergic Receptors: Subtype-Associated Signaling Responses and Structure (313 citations)
Pertussis toxin does not inhibit muscarinic-receptor-mediated phosphoinositide hydrolysis or calcium mobilization (284 citations)

What are the main themes of his work throughout his whole career to date

T. Kendall Harden performs multidisciplinary studies into Biochemistry and Biophysics in his work. Receptor and Cyclase are commonly linked in his work. He combines topics linked to GTP' with his work on Enzyme. T. Kendall Harden applies his multidisciplinary studies on Endocrinology and Internal medicine in his research. He integrates several fields in his works, including Internal medicine and Endocrinology. T. Kendall Harden conducts interdisciplinary study in the fields of Gene and G protein through his works. In his works, he undertakes multidisciplinary study on Phospholipase C and Phospholipase. With his scientific publications, his incorporates both Phospholipase and Phospholipase C. Molecular biology and Gene are two areas of study in which T. Kendall Harden engages in interdisciplinary work.

T. Kendall Harden most often published in these fields:

Biochemistry (89.74%)
Receptor (78.21%)
Enzyme (42.31%)

What were the highlights of his more recent work (between 1999-2019)?

Biochemistry (100.00%)
Receptor (88.89%)
Enzyme (55.56%)

In recent works T. Kendall Harden was focusing on the following fields of study:

T. Kendall Harden integrates Biochemistry and Computational biology in his research. In his works, T. Kendall Harden performs multidisciplinary study on Computational biology and Biochemistry. His research brings together the fields of Interleukin-21 receptor and Receptor. Interleukin-21 receptor is frequently linked to Receptor in his study. T. Kendall Harden integrates Enzyme and Molecular biology in his studies. He integrates many fields, such as Molecular biology and Enzyme, in his works. His Stereochemistry research extends to the thematically linked field of Moiety. His Stereochemistry study often links to related topics such as Moiety. He integrates many fields, such as Agonist and Antagonist, in his works.

Between 1999 and 2019, his most popular works were:

Synthesis, Biological Activity, and Molecular Modeling of Ribose-Modified Deoxyadenosine Bisphosphate Analogues as P2Y₁ Receptor Ligands (123 citations)
Methanocarba Modification of Uracil and Adenine Nucleotides: High Potency of Northern Ring Conformation at P2Y₁, P2Y₂, P2Y₄, and P2Y₁₁ but Not P2Y₆ Receptors (83 citations)
Structure−Activity Relationships of Pyridoxal Phosphate Derivatives as Potent and Selective Antagonists of P2X₁ Receptors (75 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

Michael R. Elliott;Faraaz B. Chekeni;Paul C. Trampont;Eduardo R. Lazarowski.
Nature (2009)

1472 Citations

Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Eduardo R. Lazarowski;Richard C. Boucher;T. Kendall Harden.
Molecular Pharmacology (2003)

667 Citations

Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.

Robert A. Nicholas;William C. Watt;Eduardo R. Lazarowski;Qing Li.
Molecular Pharmacology (1996)

498 Citations

Towards a revised nomenclature for P1 and P2 receptors

Bertil B. Fredholm;Maria P. Abbracchio;Geoffrey Burnstock;George R. Dubyak.
Trends in Pharmacological Sciences (1997)

462 Citations

Constitutive Release of ATP and Evidence for Major Contribution of Ecto-nucleotide Pyrophosphatase and Nucleoside Diphosphokinase to Extracellular Nucleotide Concentrations

Eduardo R. Lazarowski;Richard C. Boucher;T. Kendall Harden.
Journal of Biological Chemistry (2000)

449 Citations

Direct Demonstration of Mechanically Induced Release of Cellular UTP and Its Implication for Uridine Nucleotide Receptor Activation

Eduardo R. Lazarowski;László Homolya;Richard C. Boucher;T. Kendall Harden.
Journal of Biological Chemistry (1997)

415 Citations

Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor

Joel B. Schachter;Qing Li;José L. Boyer;Robert A. Nicholas.
British Journal of Pharmacology (1996)

345 Citations

Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.

Eduardo R. Lazarowski;William C. Watt;M. Jackson Stutts;Richard C. Boucher.
British Journal of Pharmacology (1995)

344 Citations

The experimental power of FR900359 to study Gq-regulated biological processes

Ramona Schrage;Anna Lena Schmitz;Evelyn Gaffal;Suvi Annala.
Nature Communications (2015)

258 Citations

Kinetic Scaffolding Mediated by a Phospholipase C–β and Gq Signaling Complex

Gary L. Waldo;Tiffany K. Ricks;Stephanie N. Hicks;Matthew L. Cheever.
Science (2010)

244 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for T. Kendall Harden